STAA Staar Surgical Earnings and EPS analysis

Relative Growth: Rel. Growth: 75

Relative Strength: Rel. Strength: 29

Relative Valuation: Rel. Valuation: 22

Relative Profitability: Rel. Profitability: 66

EPS in 2026 (TTM): $0.08

Last Report Period Date: Jul 3, 2026

As of September 2026, according to Staar Surgical's latest financial report, the company's current EPS (TTM) is $0.08. In 2025, the company recorded an earnings per share (EPS) of -$1.62, which represents a decrease compared to its EPS of -$0.41 in 2024. Staar Surgical's earnings per share for the quarterly report ending on Jul 3, 2026 was $0.16.

STAA earnings history

Historical annual and quarterly earnings per share (EPS) data for Staar Surgical

EPS (TTM)

$0.08

EPS Growth YoY (Quarterly)

147.1%

EPS (Quarterly)

$0.16

EPS Growth (Quarterly)

60%

The annual EPS in 2025 was -$1.62, a decrease of 295.1% from -$0.41 in 2024. For the quarter ending Jul 3, 2026, the EPS was $0.16, showing a 147.1% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of July 2026 is $0.08. In 2024, the annual EPS was -$0.41, showing a decrease of 193.2% from 2023.

STAA EPS vs price chart

STAA EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

147.1%

EPS growth YoY

-295.1%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Staar Surgical has recorded an increase in EPS of 147.1% over the last 12 months (YoY, quarterly).

STAA Earnings Waterfall

Breakdown of revenue, profit and net income for Staar Surgical

STAA Earnings vs Peers

What are the earnings of STAA compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
NVS Novartis AG	24.49	21.8%	31.2%	15.2%
ABT Abbott Laboratories	35.08	-51.4%	-1.8%	8.2%
COO Cooper Companies Inc	58.82	-4.6%	-1.2%	9.2%
STAA Staar Surgical Co	288.88	-295.1%	N/A	N/A
IRIX Iridex Corp	N/A	51.9%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.